Holen Sie sich die Stockscreener-App
28.81
1.84%
0.52
Handel nachbörslich:
28.81
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Insider Sell Alert: Karen Prange Sells 3,000 Shares of AtriCure Inc (ATRC) - GuruFocus
(ATRC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
AtriCure director Karen Prange sells $85,950 in company stock By Investing.com - Investing.com Canada
AtriCure director Karen Prange sells $85,950 in company stock - Investing.com
AtriCure (ATRC) director Prange sells 3,000 shares, keeps 26,373 - Stock Titan
Director Karen Prange granted 6,144 AtriCure (ATRC) shares - Stock Titan
AtriCure (ATRC) director Deborah Telman awarded 6,144 restricted shares - Stock Titan
AtriCure (ATRC) director Maggie Yuen receives 6,144-share restricted stock award - Stock Titan
Director Nachman Shlomo receives 6,144 AtriCure (ATRC) restricted shares - Stock Titan
Director Kristine Johnson receives 6,144-share grant at AtriCure (ATRC) - Stock Titan
AtriCure (ATRC) director Regina Groves receives 6,144-share restricted stock grant - Stock Titan
AtriCure (ATRC) director Sven Wehrwein receives 6,144-share restricted stock grant - Stock Titan
Director at AtriCure (ATRC) receives 6,144-share restricted stock grant - Stock Titan
[144] AtriCure, Inc. SEC Filing - Stock Titan
AtriCure Shareholders Approve Expanded Equity and Governance Plans - TipRanks
AtriCure (ATRC) stockholders back equity plan share increases and director slate - Stock Titan
AtriCure conference: New devices, EnCompass drive 2026 growth outlook - MSN
Insider Sell: Vinayak Doraiswamy Sells 5,000 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure (ATRC) Chief Scientific Officer sells 5,000 shares at $28.13 - Stock Titan
AtriCure Inc Annual Shareholders Meeting Transcript - GuruFocus
Loss-Making AtriCure, Inc. (NASDAQ:ATRC) Set To Breakeven - Moomoo
ATRC (NASDAQ: ATRC) Form 144 shows 5,000-share sale and planned award disposals - Stock Titan
Wellington Management holds 3,382,555 ATRC shares (6.79%) — institutional stake - Stock Titan
AtriCure Inc (ATRC) Shares Surge 5.8% -- What GF Score of 79 Tel - GuruFocus
AtriCure stock (US04963C1099): Q1 revenue jumps 14% to $141M amid return to profit - AD HOC NEWS
AtriCure, Inc.Common Stock (NQ: ATRC - FinancialContent
AtriCure (ATRC) Is Down 5.1% After Q1 Return To Profitability And Higher Revenue Guidance – What's Changed - simplywall.st
TradingKey - TradingKey
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook - sharewise.com
ATRC: Innovation, clinical trials, and new launches drive growth and reinforce market leadership - TradingView
Transcript : AtriCure, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10 - marketscreener.com
Responsive Playbooks and the ATRC Inflection - Stock Traders Daily
AtriCure, Inc. $ATRC Shares Purchased by Vanguard Group Inc. - MarketBeat
Number of shareholders of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Number of shareholders of AtriCure, Inc. – DUS:A5I - TradingView
ATRC Stock Price, Quote & Chart | ATRICURE INC (NASDAQ:ATRC) - ChartMill
Assessing AtriCure (ATRC) Valuation After A Prolonged Share Price Decline - Yahoo Finance
AtriCure Inc stock hits 52-week low at 26.62 USD By Investing.com - Investing.com Australia
AtriCure, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ATRC) 2026-05-08 - Seeking Alpha
AtriCure Inc stock hits 52-week low at 26.62 USD - Investing.com
AtriCure : Investor Presentation Q1 2026 vF - marketscreener.com
AtriCure Q1 Loss Narrows, Revenue Increases; 2026 Guidance Maintained - Moomoo
AtriCure, Inc. (NASDAQ:ATRC) Q1 2026 Earnings Call Transcript - Insider Monkey
AtriCure Earnings Call Highlights Profitable Growth Pivot - TipRanks
AtriCure Price Target Raised to $55.00/Share From $53.00 by Canaccord Genuity - Moomoo
AtriCure, Inc. 1Q 2026: Revenue $141.25M, EPS $0— 10-Q Summary - TradingView
AtriCure (NASDAQ: ATRC) posts Q1 2026 growth, swings to profit - Stock Titan
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $50 - Moomoo
AtriCure reiterates 2026 revenue $600M-$610M as BoxX-NoAF enrollment targets year-end completion - MSN
AtriCure (ATRC) reports break-even earnings for Q1 - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - The Globe and Mail
AtriCure Q1 2026 revenue up 14.3% to USD 141.2M - Medical Buyer
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $55 - Moomoo
1.04%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):